Navigation Links
Cempra, Inc. Reports First Quarter 2013 Financial and Operating Results
Date:4/25/2013

th quarter of 2012.  General and administrative expense was $2.7 million, a 172% increase compared to the quarter ended March 31, 2012, driven primarily by increased stock compensation expense and professional fees.  

First Quarter and early second quarter 2013 Highlights

  • Filed an S-3 shelf registration statement with the Securities and Exchange Commission
  • Submitted our request for an end-of-phase 2 meeting on solithromycin to the FDA
  • Clinical program updateThe company is primarily focused on the development of its two lead clinical-stage antibiotic candidates, the fluoroketolide, solithromycin, and Taksta™, the oral antibiotic being developed for staphylococcal infections.  The company expects the following events to occur during 2013:

    Solithromycin

  • 2Q13: End of Phase 2 meeting with the FDA
  • 2H13: Initiation of the IV-to-oral Phase 3 clinical trial in CABP, subject to available resources
  • 2Q13: Present the ongoing Phase 2 gonococcus clinical study at ECCMID
  • Taksta

  • 4Q13: Top-line results of the Phase 2 trial in PJI patients
  • Financial GuidanceCempra expects its research and development expense to increase due to the initiation of clinical trials during the fourth quarter of 2012.  The company's cash and equivalents are expected to be sufficient to fund current operations into 2015.  This projection does not include any funds for the initiation of the solithromycin IV-to-oral Phase 3 clinical trial in CABP.

    Conference Call and WebcastThe conference call may be accessed by dialing 877-377-7553 for domestic callers and 253-237-1151 for international callers. Please specify to the operator that you would like to join the "Cempra, Inc., First Quarter 2013 Financial Results Call, conference ID#: 33311244." The conference call will be webcast live under the investor relations section of Cempra's website at www.ce
    '/>"/>

    SOURCE Cempra, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6

    Related medicine technology :

    1. Cempra, Inc. to Present at 12th Annual Needham Healthcare Conference
    2. Cempra, Inc. to Report First Quarter 2013 Financial and Operating Results, and Host Conference Call and Webcast on April 25, 2013
    3. Cempra, Inc. to Present at Cowen and Company 33rd Annual Health Care Conference
    4. Cempra, Inc. to Report Fourth Quarter and Full Year 2012 Financial and Operating Results, and Host Conference Call and Webcast on February 28, 2013
    5. Cempra, Inc. to Present at Oppenheimer 23rd Annual Healthcare Conference
    6. Cempra, Inc. to Present at the Jefferies 2012 Global Healthcare Conference in London
    7. Cempra, Inc. to Report Third Quarter 2012 Financial and Operating Results, and Host Conference Call and Webcast on November 8, 2012
    8. Cempra, Inc., to Present at 2012 Stifel Nicolaus Healthcare Conference and NewsMakers in the Biotech Industry Conference
    9. Cempra, Inc. Reports Second Quarter 2012 Financial and Operating Results
    10. Cempra, Inc. to Present at the NIAID Workshop Bridging the Gap - Overcoming Bottlenecks in the Development of Therapeutics for Infectious Diseases
    11. Cempra, Inc. to Report Second Quarter 2012 Financial and Operating Results, and Host Conference Call and Webcast on August 8, 2012
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:11/26/2014)... Nov. 25, 2014  Breckenridge Pharmaceutical, Inc. announced ... ANDA agreement with Pii (Pharmaceutics International, Inc.) ( ... Breckenridge and Pii expect to develop and commercialize ... agreement, Pii will develop, manufacture and supply the ... products under its own label.  The drugs, comprised ...
    (Date:11/26/2014)... DUBLIN , Nov. 25, 2014 Jazz Pharmaceuticals plc ... be webcasting its corporate presentations at two upcoming investor conferences.  ... London, UK on Tuesday, December 2, 2014 at ... senior vice president and head of EUSA International, will provide an ... , 26 th Annual Piper Jaffray Healthcare Conference in ...
    (Date:11/26/2014)... DIEGO , Nov. 25, 2014 Halozyme Therapeutics, ... the Piper Jaffray Healthcare Conference in New York ... EDT/10:00 a.m. PDT . Dr. Helen Torley , ... The presentation will be webcast through the "Investors" ... a recording will be made available for 90 days following ...
    Breaking Medicine Technology:Breckenridge Pharmaceutical signs Multi-Product Generic Agreement with Pharmaceutics International, Inc. 2Jazz Pharmaceuticals Announces Participation in Two Investor Conferences 2Halozyme Therapeutics To Present At The Piper Jaffray Healthcare Conference 2
    ... MUNDELEIN, Ill. , March 18 Sysmex ... and information systems developer, today announced its selection to ... Karen Stoneman , Vice President of Human Resources, Sysmex ... practice of the "10 Characteristics of a Company That ...
    ... the "Company"), an international biopharmaceutical company with,operations in the U.S. and China , is pleased to announce the exercise of a,warrant by a principal shareholder, RimAsia Capital ... ... ... ...
    Cached Medicine Technology:Sysmex America Honored Second Consecutive Year as a 'Company That Cares' 2Sysmex America Honored Second Consecutive Year as a 'Company That Cares' 3Sysmex America Honored Second Consecutive Year as a 'Company That Cares' 4NeoStem Announces Warrant Exercise by Principal Shareholder 2NeoStem Announces Warrant Exercise by Principal Shareholder 3NeoStem Announces Warrant Exercise by Principal Shareholder 4NeoStem Announces Warrant Exercise by Principal Shareholder 5
    (Date:11/27/2014)... Angeles, CA (PRWEB) November 27, 2014 ... are thrilled to be part of Omadox, a feature film ... Festival, including an award for best ensemble cast. It is ... This is a great start to a successful cinematic career ... black and white movies. If you enjoy experimental mystery, filmed ...
    (Date:11/27/2014)... In a world enveloped in ... has lessened, and due to the intrusion of ... sleep has eroded. According to Web MD, one ... (Reference: http://www.webmd.com/sleep-disorders/features/sleep-deprivation-workplace ). This remarkably high number ... incalculable amount, leading not only to dissatisfied employers, ...
    (Date:11/27/2014)... An inventor from Buffalo, N.Y., knows that many ... she wants to lessen its impact. "After showering and ... there needed to be a way to maintain freshness ... and producible in design variations, the End Scentuous Body ... the day. It avoids bad odors, as well as ...
    (Date:11/27/2014)... New York (PRWEB) November 27, 2014 ... ) have been filed in a consolidated litigation ... LLP reports. , Documents recently updated in ... records included in the state proceeding, all of ... bipolar disorder and other psychiatric conditions. Many of ...
    (Date:11/27/2014)... WEDNESDAY, Nov. 26, 2014 (HealthDay News) -- Most babies ... a cold, the U.S. Food and Drug Administration says. ... be given to children younger than 2 because they ... agency warned. American adults average about three colds ... children get a cold, parents might want to give ...
    Breaking Medicine News(10 mins):Health News:Luciana Lagana and Gregory Graham Join the Award-Winning Cast of the Black-and-White Experimental Mystery Feature Film Omadox. 2Health News:Luciana Lagana and Gregory Graham Join the Award-Winning Cast of the Black-and-White Experimental Mystery Feature Film Omadox. 3Health News:Research Shows Surprising Number of US Workers Affected by Lack of Sleep 2Health News:New Risperdal Lawsuits Added to Philadelphia Litigation, Bernstein Liebhard LLP Reports 2Health News:New Risperdal Lawsuits Added to Philadelphia Litigation, Bernstein Liebhard LLP Reports 3Health News:New Risperdal Lawsuits Added to Philadelphia Litigation, Bernstein Liebhard LLP Reports 4Health News:Steer Clear of Cold Meds for Babies, FDA Advises 2
    ... 2009 -, CHICAGO, and CULVER CITY, Calif., June ... millions as Dr. Oz, the renowned and popular,surgeon, educator, ... Show, will debut in first-run syndication next year with ... (SPT),and distributed by SPT, it was jointly announced today ...
    ... debated whether women were more vulnerable to the disease , , FRIDAY, ... likely to get lung cancer as men who smoke, a large ... be at greater risk of lung cancer than men who never ... , "It has been known for a long time that smoking ...
    ... places third in Southern Maryland for raising,funds for ... Travel Advantage,Network (TAN), a community leader in ... third in Anne Arundel County,s Arthritis Walk,2008. TAN ... national,charities, focusing on a different cause each month., ...
    ... June 13 CardioDynamics (Nasdaq:,CDIC), the innovator and ... conference call and Internet webcast for Tuesday, July ... Company,s financial results for,second quarter 2008. The call ... Perry, and Chief Financial Officer, Steve,Loomis. A press ...
    ... from one source , , FRIDAY, June 13 (HealthDay News) -- ... at the time of the recent -- and ongoing -- ... said Friday. , "The vast majority of tomatoes in ... of those two places," Dr. David Acheson, associate commissioner for ...
    ... GROVE VILLAGE, Ill., June 13 ,St. Alexius ... Medical,Center, Elk Grove Village -- part of ... the American Stroke Association,s Get With The,Guidelines(SM)-Stroke ... the Alexian Brothers Hospital Network,s commitment and,success ...
    Cached Medicine News:Health News:Harpo Productions and Sony Pictures Television Announce Agreement to Launch DR. OZ 2Health News:Harpo Productions and Sony Pictures Television Announce Agreement to Launch DR. OZ 3Health News:Women Get Lung Cancer From Smoking at Same Rates as Men 2Health News:At the Front of the Fight Against Arthritis 2Health News:CardioDynamics Announces Second Quarter 2008 Conference Call and Webcast 2Health News:Tainted Tomatoes Likely From Florida or Mexico: FDA 2Health News:Tainted Tomatoes Likely From Florida or Mexico: FDA 3Health News:Tainted Tomatoes Likely From Florida or Mexico: FDA 4Health News:Tainted Tomatoes Likely From Florida or Mexico: FDA 5Health News:Alexian Brothers Hospital Network Receives American Stroke Association's Get With The Guidelines Gold Performance Achievement Award 2
    ... Wristrest is the standard for stabilization of the ... easily adjustable and its bar can be rotated ... eye. It allows the surgeon to stabilize his ... the fine finger movements necessary for eye surgery. ...
    Hydroview insertion forcep with very thin jaws to allow insertion through tunnel or clear cornea incision. Locking. Made in titanium....
    ... most flexible intraocular lens for ease ... The notched jaws align the implant ... fold. Ideal for lens diameters from ... on tip is great for tucking ...
    Titanium. Curved 18 mm shafts with 1.5 wide grasping tip. Flat, serrated cross action handle with dull finish....
    Medicine Products: